Dr Reddy’s USA has licensed from Ingenus the exclusive rights to commercialise Cyclophosphamide injection in strengths of 500 mg/2.5mL; 1g/5mL; and 2g/10mL in US.
Cyclophosphamide is used to treat cancer of the ovaries, breast, blood and lymph system, and nerves (mainly in children). Cyclophosphamide is also used for retinoblastoma (a type of eye cancer mainly in children), multiple myeloma (cancer in the bone marrow), and mycosis fungoides (tumors on the skin).
Dr. Reddy’s USA will commercialise the Cyclophosphamide injection in the United States and will pay Ingenus 50% of the estimated profit share, with no further consideration payable.
The parties will enter into a commercial supply agreement pursuant to which Ingenus will supply the product to Dr. Reddy’s USA.
Accor...
More News
|
|